Yu Hou

2.6k total citations
78 papers, 1.8k citations indexed

About

Yu Hou is a scholar working on Hematology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Yu Hou has authored 78 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Hematology, 20 papers in Immunology and 17 papers in Pathology and Forensic Medicine. Recurrent topics in Yu Hou's work include Platelet Disorders and Treatments (55 papers), Blood groups and transfusion (22 papers) and Autoimmune Bullous Skin Diseases (15 papers). Yu Hou is often cited by papers focused on Platelet Disorders and Treatments (55 papers), Blood groups and transfusion (22 papers) and Autoimmune Bullous Skin Diseases (15 papers). Yu Hou collaborates with scholars based in China, United States and Canada. Yu Hou's co-authors include Ming Hou, Jun Peng, Xinguang Liu, Linlin Shao, Hai Zhou, Miao Xu, Jihua Qiu, Panpan Han, Guosheng Li and Heyu Ni and has published in prestigious journals such as Nucleic Acids Research, Blood and PLoS ONE.

In The Last Decade

Yu Hou

77 papers receiving 1.7k citations

Peers

Yu Hou
Comparison fields: 5 of 100
  • Hematology 918
  • Molecular Biology 586
  • Immunology 333
  • Pathology and Forensic Medicine 313
  • Genetics 275
Toshiaki Yujiri Japan
Nunzia Montuori Italy
Michael J. Rauh Canada
Emmanuel Karouzakis Switzerland
Yasuhiro Horii Japan
Albertus T.J. Wierenga Netherlands
Akira Kitanaka Japan
Chang Kyu Oh United States
Kimberly J. Payne United States
José Perdomo Australia
Toshiaki Yujiri Japan View profile →
Citations per field, relative to Yu Hou
Yu Hou · 1×
Citations per year, relative to Yu Hou
Yu Hou · 1×

Countries citing papers authored by Yu Hou

Since Specialization
Citations

This map shows the geographic impact of Yu Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Hou more than expected).

Fields of papers citing papers by Yu Hou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Hou. The network helps show where Yu Hou may publish in the future.

Co-authorship network of co-authors of Yu Hou

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Hou. A scholar is included among the top collaborators of Yu Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Hou. Yu Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Title Journal Authors Indexed citations
1 Nynrin enhances cardiac function by inhibiting mitochondrial permeability transition pore opening upon myocardial ischemia/reperfusion injury Journal of Molecular and Cellular Cardiology Yuhan Wang, Yujing Li et al. 1
2 Eltrombopag plus diacerein vs eltrombopag in patients with ITP: a multicenter, randomized, open-label phase 2 trial Blood Lu Sun, Juan Wang et al. 2
3 The mTORC1 pathway participate in hyper-function of B cells in immune thrombocytopenia Annals of Hematology Lu Liu, Yu Hou et al. 4
4 How we treat primary immune thrombocytopenia in adults Journal of Hematology & Oncology Xinguang Liu, Yu Hou et al. 46
5 Inhibition of LDHA to induce eEF2 release enhances thrombocytopoiesis Blood Min Xin, Lingjun Wang et al. 15
6 Low-dose decitabine modulates myeloid-derived suppressor cell fitness via LKB1 in immune thrombocytopenia Blood Xiaofei Ni, Lingjun Wang et al. 12
7 Efficacy and safety of treatments in newly diagnosed adult primary immune thrombocytopenia: a systematic review and network meta-analysis EClinicalMedicine Yun Wang, Lei Sheng et al. 12
8 Glucocorticoid receptor modulates myeloid-derived suppressor cell function via mitochondrial metabolism in immune thrombocytopenia Cellular and Molecular Immunology Yu Hou, Jie Xie et al. 21
9 Low-dose decitabine modulates T-cell homeostasis and restores immune tolerance in immune thrombocytopenia Blood Panpan Han, Yu Hou et al. 47
10 Platelet autoantibody specificity and response to rhTPO treatment in patients with primary immune thrombocytopenia British Journal of Haematology Yafei Yu, Yu Hou et al. 10
11 Orelabrutinib, a Selective Bruton's Tyrosine Kinase (BTK) Inhibitor in the Treatment of Primary Immune Thrombocytopenia (ITP) Blood Tianshu Yu, Lingjun Wang et al. 8
12 Proteomic analysis and microRNA expression profiling of plasma‐derived exosomes in primary immune thrombocytopenia British Journal of Haematology Yu Hou, Panpan Han et al. 14
13 RecET direct cloning and Redαβ recombineering of biosynthetic gene clusters, large operons or single genes for heterologous expression Nature Protocols Hailong Wang, Zhen Li et al. 139
14 Participation of B‐cell‐activating factor receptors in the pathogenesis of immune thrombocytopenia Journal of Thrombosis and Haemostasis Yanan Min, Chi‐Yuen Wang et al. 15
15 Neutralizations of IL-17A and IL-21 regulate regulatory T cell/T-helper 17 imbalance via T-helper 17-associated signaling pathway in immune thrombocytopenia Expert Opinion on Therapeutic Targets Yu Hu, Xiuwen Wang et al. 15
16 Altered cytokine levels in pediatric ITP Platelets Margareta Jernås, Yu Hou et al. 9
17 Association of autoantibody specificity and response to intravenous immunoglobulin G therapy in immune thrombocytopenia: a multicenter cohort study Journal of Thrombosis and Haemostasis Jun Peng, Shenglin Ma et al. 91
18 Therapeutic effects of thalidomide in hematologic disorders: a review Frontiers of Medicine Miao Xu, Yu Hou et al. 12
19 Th22 Cells as Well as Th17 Cells Expand Differentially in Patients with Early-Stage and Late-Stage Myelodysplastic Syndrome PLoS ONE Linlin Shao, Lei Zhang et al. 37
20 The value of transtelephonic electrocardiogram monitoring system during the “Blanking Period” after ablation of atrial fibrillation Journal of Electrocardiology Jun Liu, Yu Hou et al. 11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Toshiaki Yujiri Breakdown of academic impact, for papers by Nunzia Montuori Breakdown of academic impact, for papers by Michael J. Rauh Breakdown of academic impact, for papers by Emmanuel Karouzakis Breakdown of academic impact, for papers by Yasuhiro Horii Breakdown of academic impact, for papers by Albertus T.J. Wierenga Breakdown of academic impact, for papers by Akira Kitanaka Breakdown of academic impact, for papers by Chang Kyu Oh Breakdown of academic impact, for papers by Kimberly J. Payne Breakdown of academic impact, for papers by José Perdomo
Rankless by CCL
2026